Consensus Beta Bionics, Inc. CBOE

Stocks

BBNX

US08659B1026

Advanced Medical Equipment & Technology

Market Closed - CBOE 15:59:56 2026-09-14 EDT			5-day change	1st Jan Change
16.72 ^USD	+0.78%		-14.70%	-45.52%

08-12	BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50	MT
08-11	BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50	MT

f9065.BFUULYMxR_U_Qriz8L7_rgYKEjBMpliOK5aKM7HkHzY.Nw1FQsEIH6RNOs_5pPuKwjBAI34l8BP6Y67GfYC3SGA2bXJf8H0LkFkp6Q~e12a1651cf296a13100a463d75e2faa2

Analysts' recommendations: Beta Bionics, Inc.

09-14	Truist Lifts Price Target on Beta Bionics to $23 From $22, Keeps Buy Rating	MT
08-12	BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50	MT
08-11	BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50	MT
07-28	UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating	MT
07-13	Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating	MT
05-18	BofA Adjusts Price Target on Beta Bionics to $11 From $23	MT
04-15	Truist Cuts Price Target on Beta Bionics to $18 From $25, Keeps Buy Rating	MT
02-09	UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target	MT
02-02	Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating	MT
01-27	TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17	MT
01-09	Top Midday Decliners	MT
01-09	Beta Bionics Shares Fall After BofA Securities Downgrade	MT
01-09	BofA Securities Downgrades Beta Bionics to Neutral From Buy, Adjusts Price Target to $28 From $33	MT
12-18	Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating	MT
25-10-29	Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating	MT
25-10-01	Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18	MT
25-09-22	Truist Raises Price Target on Beta Bionics to $28 From $21, Keeps Buy Rating	MT
25-07-30	Truist Raises Price Target on Beta Bionics to $21 From $18, Keeps Buy Rating	MT
25-06-16	Truist Securities Initiates Beta Bionics at Buy With $26 Price Target	MT
25-05-30	Wolfe Research Initiates Coverage on Beta Bionics With Outperform Rating, $20 Price Target	MT
25-05-30	Goldman Sachs Initiates Coverage on Beta Bionics With Neutral Rating, $16 Price Target	MT
25-02-24	Stifel Initiates Beta Bionics at Buy With $25 Price Target	MT
25-02-24	Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target	MT
25-02-24	Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target	MT
25-02-20	Baird Initiates Beta Bionics at Neutral With $20 Price Target	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	THERMO FISHER SCIENTIFIC, INC.					+5.79%
	DANAHER CORPORATION					+14.46%
	INTUITIVE SURGICAL, INC.					+29.04%
	BOSTON SCIENTIFIC CORPORATION					+45.22%
	SIEMENS HEALTHINEERS AG					+19.07%
	EDWARDS LIFESCIENCES CORPORATION					+19.67%
	AGILENT TECHNOLOGIES, INC.					+19.07%
	WATERS CORPORATION					+8.42%
	RESMED, INC.					+12.9%
	Average					+19.29%
	Weighted average by Cap.					+17.38%